Hedge Funds Are Buying Bristol Myers Squibb Co. (BMY)

Page 2 of 2
Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Merck & Co., Inc. (NYSE:MRK) 65 0 4
GlaxoSmithKline plc (ADR) (NYSE:GSK) 21 0 0
AstraZeneca plc (ADR) (NYSE:AZN) 17 0 0
Eli Lilly & Co. (NYSE:LLY) 38 0 5
AbbVie Inc (NYSE:ABBV) 41 1 3

Using the returns shown by the previously mentioned tactics, regular investors must always pay attention to hedge fund and insider trading activity, and Bristol Myers Squibb Co. (NYSE:BMY) applies perfectly to this mantra.

Discover how hedge fund piggybacking can benefit you

Page 2 of 2